# US 2021/0330686 A1 · Composition containing 2'-fucosyllactose for preventing stroke

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330686 A1
- Document ID: US20210330686A1
- Status: Published application
- Kind: A1
- Application number: 16/613,665
- Filed: 2019-05-15
- Published: 2021-10-28
- Earliest claimed: 2018-05-15
- Assignees: Advanced Protein Technologies Corp.
- Applicants: Advanced Protein Technologies Corp.
- Inventors: Chul Soo SHIN; Jong Won YOON; Chang Ku JEONG; Young Ha SONG; Seong Jin YU
- Web page: https://patentgrep.com/patent/US20210330686A1

## CPC

- A61K 31/702: Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A23L 33/125: containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates (indigestible substances A23L33/21)
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Disclosed is a food or pharmaceutical composition containing 2′-fucosyllactose (2′-FL) for preventing a stroke. The food or pharmaceutical composition containing 2′-fucosyllactose (2′-FL) is highly effective in preventing a stroke.

## Claims

### Claim 1

A pharmaceutical composition comprising 2′-fucosyllactose (2′-FL) for preventing a stroke.

### Claim 2 (depends on 1)

The pharmaceutical composition according to claim 1, wherein the stroke is an ischemic stroke.

### Claim 3

A food composition comprising 2′-fucosyllactose (2′-FL) for preventing a stroke.

### Claim 4 (depends on 3)

The food composition according to claim 3, wherein the stroke is an ischemic stroke.
